Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942011000400002
Brazilian Journal of Anesthesiology
Artigo Científico

Avaliação clínica de duas ke0 no mesmo modelo farmacocinético de propofol: estudo da perda e recuperação da consciência

Clinical evaluation of two ke0 in the same pharmacokinetic propofol model: study on loss and recovery of consciousness

Ricardo Francisco Simoni; Luis Otávio Esteves; Luiz Eduardo de Paula Gomes Miziara; Luiz Marciano Cangiani; Gustavo Groth Oliveira Alves; André Luz Pereira Romano; Paula Úrica Hansen; Pedro Thadeu Galvão Vianna

http://dx.doi.org/10.1590/S0034-70942011000400002 Braz J Anesthesiol, vol.61, n4, p.402-408, 2011
PDF Português
PDF English
Downloads: 1
Views: 1356

Resumo

JUSTIFICATIVA E OBJETIVOS: A constante de equilíbrio entre o plasma e o sítio efetor (ke0) é utilizada pelos modelos farmacocinéticos para prever a concentração do fármaco em seu local de ação (Ce). Seria interessante que a Ce de propofol fosse semelhante na perda e na recuperação da consciência. O objetivo deste estudo foi avaliar o desempenho clínico de duas diferentes ke0 (rápida = 1,21 min-1 e lenta = 0,26 min-1) com relação à Ce durante a perda e a recuperação da consciência, usando o modelo farmacocinético de Marsh. MÉTODO: Participaram deste estudo 20 voluntários adultos sadios do sexo masculino. Em todos os voluntários, administrou-se propofol em regime de infusão alvo-controlada, modelo farmacocinético de Marsh ke0 rápida e, em outra oportunidade, usou-se o mesmo modelo farmacocinético com a ke0 lenta. Inicialmente, o propofol foi infundido em concentração-alvo plasmática de 3,0µg.mL-1. A perda de consciência e a recuperação de consciência basearam-se na resposta ao estímulo verbal. A Ce foi anotada no momento da perda e da recuperação da consciência. RESULTADOS: Na perda e na recuperação da consciência a Ce pela ke0 rápida foi diferente (3,64 ± 0,78 e 1,47 ± 0,29µg.mL-1, respectivamente, p < 0,0001), enquanto com a ke0 lenta a Ce foi semelhante (2,20 ± 0,70 e 2,13 ± 0,43µg.mL-1, respectivamente, p = 0,5425). CONCLUSÕES: Do ponto de vista clínico, a ke0 lenta (0,26 min-1) incorporada ao modelo farmacocinético de Marsh apresentou melhor desempenho que a ke0 rápida (1,21 min-1), uma vez que a concentração de propofol prevista em seu local de ação na perda e recuperação da consciência foi semelhante.

Palavras-chave

ANESTÉSICOS, Venoso, FARMACOLOGIA, EQUIPAMENTOS, Bomba de Infusão

Abstract

BACKGROUND AND OBJECTIVE: The constant equilibrium between the plasma and effect site (ke0) is used by pharmacokinetic models to calculate a drug concentration in its site of action (Ce). It would be interesting if Ce of propofol was similar at loss and recovery of consciousness. The objective of this study was to evaluate the clinical performance of two different ke0 (fast = 1.21 min-1, and slow = 0.26 min-1) in relation to Ce during loss and recovery of consciousness using Marsh pharmacokinetic model. METHODS: Twenty healthy adult male volunteers participated in this study. In all volunteers propofol was administered as target-controlled infusion, Marsh pharmacokinetic model for fast ke0 and, at a different time, the same pharmacokinetic model with slow ke0 was used. Initially, propofol was infused with a serum target-controlled infusion of 3.0 µg.mL-1. Loss of consciousness and recovery of consciousness were based on response to verbal stimulus. Ce was recorded at the moment of loss and recovery of consciousness. RESULTS: On loss and recovery of consciousness, the Ce for fast ke0 was different (3.64 ± 0.78 and 1.47 ± 0.29 µg.mL-1, respectively, p < 0.0001), while with slow ke0 the Ce was similar (2.20 ± 0.70 and 2.14 ± 0.43 µg.mL-1, respectively, p = 0.5425). CONCLUSIONS: Clinically, the slow ke0 (0.26 min-1) incorporated in the Marsh pharmacokinetic model showed better performance than the fast ke0 (1.21 min-1), since the calculated concentration of propofol at the effect site on loss and recovery of consciousness was similar.

Keywords

Pharmacokinetics, Propofol, administration and dosage, Intraoperative Awareness, Drug Delivery Systems

Referências

Kenny GN, White M. Intravenous propofol anaesthesia using a computerised infusion system. Anaesthesia. 1991;46:156-157.

Glen JB. The development of "Diprifusor: a TCI system for propofol. Anaesthesia. 1998;53(^sSuppl):13-21.

Marsh B, White M, Morton N. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth. 1991;67:41-48.

Vuyk J, Engbers FH, Lemmens HJ. Phamacodynamics of propofol in female patients. Anesthesiology. 1992;77:3-9.

Smith C, McEwan AI, Jhaveri R. The interaction of fentanyl on the Cp50 of propofol for loss os consciouness and skin incision. Anesthesiology. 1994;81:820-828.

Wakeling HG, Zimmerman JB, Howell S. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness?. Anesthesiology. 1999;90:92-97.

Struys M, Versichelen L, Rolly G. Influence of pre-anaesthetic medication on target propofol concentration using a "Diprifusor" TCI system during ambulatory surgery. Anaesthesia. 1998;53(^s1):68-71.

Milne SE, Troy A, Irwin MG. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth. 2003;90:127-131.

Doufas AG, Bakhshandeh M, Bjorksten AR. Autometed responsiveness test (ART) predicts loss of consciousness and adverse physiologic responses during propofol conscious sedation. Anesthesiology. 2001;94:585-592.

Chortkoff BS, Eger EII, Crankshaw DP. Concentrations of desflurane and propofol that suppress response to command in humans. Anesth Analg. 1995;81:737-743.

Wessen A, Persson PM, Nilsson A. Concentration-effect relationships of propofol after total intravenous anesthesia. Anesth Analg. 1993;77:1000-1007.

Nora FS. Anestesia venosa total em regime de infusão alvo-controlada: uma análise evolutiva. Rev Bras Anestesiol. 2008;58:179-192.

Iwakiri H, Nishihara N, Nagata O. Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening. Anesth Analg. 2005;100:107-110.

Sheiner LB, Stanski DR, Vozeh S. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther. 1979;25:358-371.

Kenny GN. Ke0 of propofol evaluated with AEPex. 1996.

Billard V, Gambus PL, Chamoun N. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharm Ther. 1997;61:45-58.

Schnider TW, Minto CF, Gambus PL. The influence of method of adminstration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology. 1998;88:1170-1182.

Schnider TW, Minto CF, Shafer SL. The influence of age on propofol pharmacodynamic. Anesthesiology. 1999;90:1502-1516.

Struys MM, De Smet T, Depoorter B. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology. 2000;92:399-406.

White M, Schenkels MJ, Engbers FHM. Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth. 1999;82:333-339.

Struys MM, Coppens MJ, De Neve N. Influence of administration rate on propofol plasma-effect site equilibration. Anesthesiology. 2007;107:386-396.

Doufas AG, Bakhshandeh M, Bjorksten AR. Induction speed is not a determinant of propofol phamacodynamics. Anesthesiology. 2004;101:1112-1121.

Barakat AR, Sutcliffe N, Schwab M. Effect site concentration during propofol TCI sedation: a comparison of sedation score with two pharmacokinetic models. Anaesthesia. 2007;62:661-666.

Nunes CS, Ferreira DA, Antunes L. Individual effect-site concentrations of propofol at return of consciousness are related to the concentrations at loss of consciouness and age in neurosurgical patients. J Clin Anesth. 2009;21:3-8.

Sepúlveda P, Nunez G, Recart A. Induction TCI a sitio efector de propofol: evaluación clínica de dos diferentes ke0. Rev Argent Anestesiol. 2007;65:89-95.

Absalom AR, Mani V, De Smet T. Pharmacokinetic models for propofol: defining and illuminating the devil in the detail. Br J Anesth. 2009;103:26-37.

Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology. 2000;92:727-738.

Gan TJ, Glass PS, Sigl J. Women emerge from general anesthesia with propofol/alfentanil/nitrous oxide faster than men. Anesthesiology. 1999;90:1283-1287.

Kodaka M, Suzuki T, Maeyama A. Gender differences between predicted and measured propofol Cp50 for loss of consciousness. J Clin Anesth. 2006;18:486-489.

White M, Kenny GNC, Schraag S. Use of target controlled infusion to derive age and gender covariates for propofol clearance. Clin Pharmacokinet. 2008;47:119-127.

Gajraj RJ, Doi M, Mantzaridis H. Comparison of bispectral EEG analysis and auditory evoked potentials for monitoring depth of anaesthesia during propofol anaesthesia. Br J Anaesth. 1999;82:672-678.

Irwin MG, Hui TWC, Milne SE. Propofol effective concentration 50 and its relationship to bispectral index. Anaesthesia. 2002;57:242-248.

Lysakowski C, Elia N, Czarnetzki C. Bispectral and spectral entropy indices at propofol-induced loss of consciousness in young and elderly patients. Br J Anaesth. 2009;103:387-393.

Iannuzzi M, Iannuzzi E, Rossi F. Relationship between bispectral index, electroencephalografic state entropy and effect-site EC50 for propofol at different clinical endpoints. Br J Anaesth. 2005;94:613-616.

Schraag S, Bothner U, Gajraj RJ. The performance of electroencephalogram bispectral index and auditory evoked potential index to predict loss of consciousness during propofol infusion. Anesth Analg. 1999;89:1311-1315.

Pilge S, Zanner R, Schneider G. Time delay of index calculation: analisys of cerebral state, bispestral and narcotrend indices. Anesthesiology. 2006;104:488-494.

Iwakiri H, Nagata O, Matsukawa T. Effect-site concentration of propofol for recovery of consciouness is virtually independent of fentanyl effect-site concentration. Anesth Analg. 2003;96:1651-1655.

Practice advisory for intraoperative awareness and brain function monitoring. Anesthesiology. 2006;104:847-864.

5dd6ba3d0e8825ba0513f286 rba Articles
Links & Downloads
2352-2291 (Eletrônico) 0104-0014 (Impresso)
Braz J Anesthesiol ©2024 Todos os direitos reservados.

Braz J Anesthesiol

Share this page
Page Sections